Jubilant Ingrevia Ltd (JUBLINGREA)
₹675.30
Mkt cap
₹10,757 Cr
P/E ratio
33.80
P/B
3.45
Div yield
0.74%
ROE
9.52%
ROCE
11.40%
EPS (TTM)
₹19.98
Book value
₹196
52W range
541–764
Sector
Commodities
Price history
Previous close
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. [1]
NSE JUBLINGREABSE 543271
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−11.59% from high₹675
₹541+24.76% from low₹764
Current
₹675.30
Prev close
₹677.60
Day
−0.34%
Price performance
1D
−0.34%
1W
−2.59%
1M
−8.97%
3M
+8.99%
6M
+19.50%
1Y
−7.68%
YTD
−7.02%
Financials
Revenue, profit & margin
P/E ratio
33.8×
JUBLINGREA is 16% above the sector median of 29.1×
JUBLINGREA33.8×
Sector median29.1×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,075 | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 | |
| Expenses | 958 | 902 | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 | 924 | 1,016 | 1,101 | |
| Operating Profit | 117 | 118 | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 | 126 | 163 | 199 | |
| OPM % | 11% | 12% | 10% | 8% | 11% | 12% | 13% | 14% | 14% | 12% | 12% | 14% | 15% | |
| Other Income | 8 | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | -4 | 9 | 10 | |
| Interest | 11 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 | 12 | 17 | |
| Depreciation | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 | 48 | 51 | |
| Profit before tax | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 | |
| Tax % | 29% | 28% | 30% | 43% | 26% | 26% | 27% | 27% | 25% | 25% | 28% | 23% | 25% | |
| Net Profit | 58 | 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 | |
| EPS in Rs | 3.62 | 3.61 | 2.42 | 1.84 | 3.06 | 3.70 | 4.36 | 4.65 | 4.71 | 4.36 | 2.94 | 5.43 | 6.64 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202645.22%Promoter
Promoters45.22%
FIIs6.49%
DIIs24.98%0.22
Public22.30%0.23
Government0.02%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,575.00 | 60.53 | 1,60,316 | 0.73% | 884 | +28.18% | 4,552 | +21.27% | 31.02% |
| FLUOROCHEM | ₹4,530.50 | 80.57 | 49,768 | 0.07% | 219 | +21.43% | 1,588 | +23.97% | 9.64% |
| NAVINFLUOR | ₹8,603.50 | 55.51 | 44,149 | 0.18% | 243 | +107.67% | 1,045 | +44.07% | 20.96% |
| DEEPAKNTR | ₹1,642.10 | 28.27 | 22,397 | 0.46% | 345 | +207.50% | 2,578 | +36.39% | 11.37% |
| AETHER | ₹1,619.50 | 89.59 | 21,495 | 0.00% | 63 | +27.98% | 327 | +27.25% | 11.92% |
| ATUL | ₹6,312.50 | 23.36 | 18,585 | 0.48% | 254 | +91.99% | 1,848 | +25.03% | 14.90% |
| AARTIIND | ₹490.70 | 34.08 | 17,799 | 0.20% | 155 | +256.47% | 2,387 | +42.51% | 6.86% |
| JUBLINGREA | ₹675.35 | 33.83 | 10,757 | 0.74% | 106 | +40.91% | 1,300 | +25.28% | 11.37% |
| Median: 91 Co. | ₹349.00 | 29.05 | 1,043 | 0.28% | 14 | +51.01% | 175 | +26.39% | 13.63% |
Filings
Annual reports6
Concall transcripts56
TranscriptJul 2026PPTJul 2026RECJul 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptOct 2025PPTOct 2025RECOct 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptMar 2025PPTMar 2025TranscriptJan 2025PPTJan 2025RECJan 2025TranscriptOct 2024TranscriptOct 2024PPTOct 2024TranscriptJul 2024
Credit ratings6
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 26 AugShareholder Meeting / Postal Ballot-Outcome of AGM 26 Aug - 7th AGM held August 26, 2026; all resolutions passed, including Rs.2.50 final dividend.Announcement under Regulation 30 (LODR)-Press Release / Media Release 18 Aug - Jubilant Ingrevia to acquire 40% stake in Zettaone for ₹189.2 crore; closes by November 2026 and September 2027.Announcement under Regulation 30 (LODR)-Acquisition 18 Aug - Jubilant Ingrevia to acquire 40% stake in Zettaone for ₹189.2 crore in two tranches.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Aug - Management of the Company is participating in the Equirus Annual India Conference 2026 on 13th & 14th August, 2026